A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Anileridine
Debrisoquine
The therapeutic efficacy of Debrisoquine can be decreased when used in combination with Antipyrine.
Anileridine
Tienilic acid
The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Antipyrine.
Anileridine
Pargyline
The therapeutic efficacy of Pargyline can be decreased when used in combination with Antipyrine.
Anileridine
Guanethidine
The therapeutic efficacy of Guanethidine can be decreased when used in combination with Antipyrine.
Anileridine
Bretylium
The therapeutic efficacy of Bretylium can be decreased when used in combination with Antipyrine.
Anileridine
Diazoxide
The therapeutic efficacy of Diazoxide can be decreased when used in combination with Antipyrine.
Anileridine
Trimethaphan
The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Antipyrine.
Anileridine
Pentolinium
The therapeutic efficacy of Pentolinium can be decreased when used in combination with Antipyrine.
Anileridine
Deserpidine
The therapeutic efficacy of Deserpidine can be decreased when used in combination with Antipyrine.
Anileridine
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Antipyrine.
Anileridine
Vemurafenib
The serum concentration of Antipyrine can be increased when it is combined with Vemurafenib.
Anileridine
Sodium phosphate, monobasic
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Antipyrine.
Anileridine
Osimertinib
The serum concentration of Antipyrine can be decreased when it is combined with Osimertinib.
Anileridine
Certoparin
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Certoparin.
Anileridine
Tolvaptan
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Tolvaptan.
Anileridine
Methsuximide
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Methsuximide.
Anileridine
Tetrandrine
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Tetrandrine.
Anileridine
Lomerizine
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Lomerizine.
Anileridine
Emopamil
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Emopamil.
Anileridine
Dexverapamil
The risk or severity of hyperkalemia can be increased when Antipyrine is combined with Dexverapamil.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3